Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised... by Kavitha Muthiah, Jerry R Greenfield, Nicole K Bart, Peter MacDonald, Eugene Kotlyar, Christopher S Hayward, Andrew Jabbour, Lisa Mary Raven, Christopher A Muir, Cassia Kessler Iglesias

Get full text

Severe Hypertriglyceridemia Associated With Everolimus Treatment After Heart Transplantation by Phillip Lo, MD, MMed, Katherine Kearney, MBBS, MMed, FRACP, Christopher A. Muir, MBBS, FRACP, Ning Song, MBBS, FRACP, John A. Eisman, MBBS, PhD, FRACP, Peter S. Macdonald, MBBS, MD, PhD, FRACP

Get full text

Immune Related Adverse Events of the Thyroid – A Narrative Review by Christopher A. Muir, Venessa H. M. Tsang, Venessa H. M. Tsang, Venessa H. M. Tsang, Alexander M. Menzies, Alexander M. Menzies, Alexander M. Menzies, Alexander M. Menzies, Roderick J. Clifton-Bligh, Roderick J. Clifton-Bligh, Roderick J. Clifton-Bligh

Get full text

Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation by Lisa M. Raven, MBBS, FRACP, Christopher A. Muir, MBBS (Hons), FRACP, PhD, Ricardo C. Deveza, MD, FRACP, Cassia Kessler Iglesias, MD (Hons), FRACP, Nicole K. Bart, MBBS (Hons), BSc (Med Sci), DPhil (Oxon), FRACP, Kavitha Muthiah, MBChB, PhD, FRACP, Eugene Kotlyar, MBBS, MD, MPVD, FRACP, Christopher S. Hayward, BMedSc, MBBS (Hons), MD, FRACP, Peter S. Macdonald, MBBS, MD, PhD, FRACP, Andrew Jabbour, BSc (Med), MBBS (Hons), PhD, FRACP, Jerry R. Greenfield, MBBS (Hons 1), PhD, FRACP

Get full text